Serratia marcescens: use of detailed characterization of strains to evaluate an increase of isolates in an intensive care unit.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001770:Blood Bactericidal Activity; D002452:Cell Count; D002648:Child; D003428:Cross Infection / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D004756:Enterobacteriaceae Infections / Q000209:etiology* / Q000401:mortality; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007362:Intensive Care Units; D008826:Microbial Sensitivity Tests; D018805:Sepsis / Q000382:microbiology*; D012703:Serotyping; D012706:Serratia marcescens / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents